South Korea grants approval to Novavax Covid-19 vaccine
South Korea’s MFDS granted approval to a BLA from SK bioscience for Novavax’s recombinant, adjuvanted Covid-19 vaccine, Nuvaxovid.
Source: pharmaceutical-technology.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Preference Management Solution. Real-time updates on events, politics, business and more.